Cubist Systematic Strategies’s Vera Therapeutics VERA Stock Holding History

Cubist Systematic Strategies’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.82M	Buy	+96,871	New	+$2.24M	0.01%	1342
2025 Q1	–	Sell	-56,921	Closed	-$2.41M	–	3575
2024 Q4	$2.41M	Sell	56,921 -45,021	-44%	-$1.99M	0.02%	1243
2024 Q3	$4.51M	Buy	101,942 +48,002	+89%	+$1.82M	0.03%	896
2024 Q2	$1.95M	Buy	53,940 +26,810	+99%	+$1.06M	0.01%	1350
2024 Q1	$1.17M	Buy	27,130 +19,197	+242%	+$684K	0.01%	2041
2023 Q4	$122K	Buy	+7,933	New	+$101K	﹤0.01%	3135
2023 Q2	–	Sell	-159,914	Closed	-$1.24M	–	4347
2023 Q1	$1.24M	Buy	+159,914	New	+$1.23M	0.01%	2006
2022 Q4	–	Sell	-5,000	Closed	-$107K	–	4616
2022 Q3	$107K	Buy	+5,000	New	+$93.6K	﹤0.01%	3995

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's VERA Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Vera Therapeutics (VERA) in Q3 2025: 96,871 shares worth $2.82M. The stake represents 0.01% of the portfolio and ranks #1342 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in VERA as recently as Q4 2024.

Cubist Systematic Strategies first reported a position in VERA in Q3 2022 and has held it in 8 quarters since. The position peaked at $4.51M in Q3 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

Cubist Systematic Strategies held 96,871 shares of Vera Therapeutics worth $2.82M as of Q3 2025.
Vera Therapeutics was a new Cubist Systematic Strategies position in Q3 2025.
Vera Therapeutics made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1342 holding.
Cubist Systematic Strategies first reported a position in Vera Therapeutics in Q3 2022 and has held it in 8 quarters since.
Cubist Systematic Strategies's Vera Therapeutics position peaked at $4.51M in Q3 2024.
175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.